The stock of MAIA Biotechnology Inc (MAIA) has seen a 6.29% increase in the past week, with a 1.64% gain in the past month, and a 6.29% flourish in the past quarter. The volatility ratio for the week is 1.70%, and the volatility levels for the past 30 days are at 3.71% for MAIA. The simple moving average for the last 20 days is 4.85% for MAIA stock, with a simple moving average of -12.65% for the last 200 days.
Is It Worth Investing in MAIA Biotechnology Inc (AMEX: MAIA) Right Now?
The 36-month beta value for MAIA is also noteworthy at 0.05. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for MAIA is 21.93M, and at present, short sellers hold a 1.64% of that float. The average trading volume of MAIA on June 18, 2025 was 242.61K shares.
MAIA) stock’s latest price update
The stock price of MAIA Biotechnology Inc (AMEX: MAIA) has surged by 12.05 when compared to previous closing price of 1.66, but the company has seen a 6.29% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-06-18 that CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies.
MAIA Trading at 2.10% from the 50-Day Moving Average
After a stumble in the market that brought MAIA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.13% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MAIA starting from Smith Stan, who purchase 33,333 shares at the price of $1.50 back on Jun 03 ’25. After this action, Smith Stan now owns 1,305,059 shares of MAIA Biotechnology Inc, valued at $50,000 using the latest closing price.
Guerrero Ramiro, the Director of MAIA Biotechnology Inc, purchase 20,000 shares at $1.50 during a trade that took place back on May 08 ’25, which means that Guerrero Ramiro is holding 588,218 shares at $30,000 based on the most recent closing price.
Stock Fundamentals for MAIA
The total capital return value is set at -2.71. Equity return is now at value -1131.02, with -191.48 for asset returns.
Currently, EBITDA for the company is -16.96 million with net debt to EBITDA at 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.35.
Conclusion
In summary, MAIA Biotechnology Inc (MAIA) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
